Insider · CIK 0001565795

CICIC DRAGAN

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001565795

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-07	SLSSELLAS Life Sciences Group, Inc.A Award	SVP, Chief Development Officer	AAward	+300K sh	—	—	557,805
2025-12-03	SLSSELLAS Life Sciences Group, Inc.J Other	SVP, Chief Development Officer	JOther	−63.8K sh	$1.50	−$95.7K	257,805
2025-01-10	SLSSELLAS Life Sciences Group, Inc.A Award	SVP, Chief Development Officer	AAward	+113K sh	—	—	228,328
2025-01-10	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	SVP, Chief Development Officer	AAward	+170K sh	—	—	169,500
2025-01-10	SLSSELLAS Life Sciences Group, Inc.A Award	SVP, Chief Development Officer	AAward	+81.3K sh	—	—	309,628
2024-12-04	SLSSELLAS Life Sciences Group, Inc.J Other	SVP, Chief Development Officer	JOther	−8,256 sh	$1.13	−$9,329.28	115,328
2017-03-14	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Chief Technology Officer	AAward	+75K sh	$1.39	+$104K	75,000
2016-04-15	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Chief Technology Officer	AAward	+50K sh	$1.99	+$99.5K	50,000
2015-05-07	ATNMActinium Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technology Officer	DDisposition to Issuer	−2,380 sh	$2.52	−$5,997.6	560
2015-05-07	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Chief Technology Officer	AAward	+2,874 sh	$2.52	+$7,242.48	2,874
2015-05-07	ATNMActinium Pharmaceuticals, Inc.F Tax Payment	Chief Technology Officer	FTax Payment	−560 sh	$2.52	−$1,411.2	560
2015-02-18	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Chief Technology Officer	AAward	+35K sh	$3.58	+$125K	35,000
2014-02-21	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Chief Technology Officer	AAward	+31.5K sh	$5.55	+$175K	31,500
2014-02-21	ATNMActinium Pharmaceuticals, Inc.A Award	Chief Technology Officer	AAward	+3,500 sh	$5.55	+$19.4K	3,500

Recent filings

Accepted (ET)
Jan 94
CICIC DRAGAN0001104659-26-002506
SEC(opens sec.gov)
Dec 54
CICIC DRAGAN0001104659-25-118882
SEC(opens sec.gov)
Jan 144
CICIC DRAGAN0001104659-25-003494
SEC(opens sec.gov)
Dec 54
CICIC DRAGAN0001104659-24-125944
SEC(opens sec.gov)
Mar 164
Actinium Pharmaceuticals, Inc.0001213900-17-002450
SEC(opens sec.gov)
Apr 184
Actinium Pharmaceuticals, Inc.0001213900-16-012632
SEC(opens sec.gov)
May 224
Actinium Pharmaceuticals, Inc.0001213900-15-004133
SEC(opens sec.gov)
Mar 164
Actinium Pharmaceuticals, Inc.0001213900-15-001820
SEC(opens sec.gov)

Companies

Address

C/O SELLAS LIFE SCIENCES GROUP, INC., 7 TIMES SQUARE, SUITE 2503

NEW YORK, NY, 10036